Login / Signup

Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study.

Adam StrzelczykMarta MaschioMax C PenselAntonietta CoppolaSatoru TakahashiShuichi IzumotoEugen TrinkaSheri CappucciRicardo Sainz-FuertesVicente Villanueva
Published in: Neurology and therapy (2024)
Although PER was effective and generally well tolerated when used to treat individuals with a range of epilepsy aetiologies in clinical practice, variability in its effectiveness and tolerability across the subgroups indicates that PER may be particularly useful for individuals with specific epilepsy aetiologies.
Keyphrases
  • clinical practice
  • randomized controlled trial
  • open label
  • temporal lobe epilepsy
  • clinical trial
  • double blind